Injection of Glatiramer Acetate Depot Results in T1 and T2 Lesion Reduction in Relapsing MS.

Published Date: 01 Mar 2023

Secondary results from a phase 3 study show that patients with multiple sclerosis receiving glatiramer acetate depot therapy have significantly fewer new T1 enhancing lesions and new, enlarging hyperintense T2 lesions.

Read Full News

Latest News

This Unusual Syndrome of the Face Could Be an Early Sign of AML

Case started with severe pain and numbness

New Autism Committee Chair Founded a Leucovorin Telehealth Company

Drug has been promoted as a treatment for autism

Possible Drug-Drug Interactions Flagged for Older Americans

— Many are on 5+ prescription drugs or dietary supplements

A Dementia Vaccine? Most Americans Say Yes

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

The Brain as Two Organs; Epstein-Barr and MS; Indigenous Bolivians and Dementia

— News and commentary from the world of neurology and neuroscience

Todays Updates

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Todays Updates

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Latest News

Case started with severe pain and numbness

Drug has been promoted as a treatment for autism

— Many are on 5+ prescription drugs or dietary supplements

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

— News and commentary from the world of neurology and neuroscience

News All Time

Federal Committee Looks Backward as Autism Science Moves Forward

In its second meeting, federal autism committee advances plan that may stymie promising research

New Migraine Prevention Guidance Highlights CGRP Drugs, Broad Eligibility

Guidelines from AAN and AHS get first update since 2012

Will Patient Deaths Derail the CAR-T Train in Autoimmune Disease?

Novartis, BMS reportedly halt trials; first serious blow to burgeoning field

Alzheimer's Genetic Risk; Underreported Dementia; Exercise or Nap After Sleep Loss?

News and commentary from the world of neurology and neuroscience

Study: Chronic Pain May Really Be 'All in Your Head'

Protein from skull bone marrow appears to play a key role

Autism-Vaccine Researcher Says He Stole $1M in CDC Grant Funds

Extradited Danish physician admits guilt in operating wire fraud scheme

1,081 Injuries Tied to Device; Military's COVID Shot Probe; Teen Vax Coverage Slides

Health news and commentary gathered by MedPage Today staff

Is Paxlovid Any Better Than Placebo for Long COVID?

In three major symptom phenotypes, randomized trial finds no benefit

Rare Brain Disorder Gets Its First FDA Drug Approval

Zilganersen targets protein buildup that drives Alexander disease

Parkinson's Risk and Carbon Monoxide: What a New Study Found

Analysis offers surprising twist to the smoking-Parkinson's puzzle

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

Motor function may improve with adjunctive apitegromab

Alzheimer's and Liver Enzymes; Pivotal Trial Hold; Lasker Awards Honor Brain Science

News and commentary from the world of neurology and neuroscience

Recommended News For You

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

PSA Screening Overdiagnosis Rises Sharply With Age

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

Hemihedral resection not necessary for neuroendocrine surgery after appendicitis

PSA Often Unchanged With Enzalutamide Progression

Breast Cancer Patients Living Longer Post-Medicaid Expansion

Recommended Articles For You

Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself 

Screening for Early Red-Cell Deformability Changes: Clinical Relevance, Mechanisms, and Emerging Diagnostics 

Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment 

Case Study: Genomic Medicine in Precision Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?

2.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

3.

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

4.

GLP-1 receptor agonists, cancer risk and questionable significance

5.

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

1.

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment

2.

Gynecologic Oncology: Advances, Education, and Clinical Excellence

3.

Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology

4.

Strategic Developments in Hematology and Quality Improvement

5.

Altered Marrow Cell-Production Dynamics During Chronic Hematologic Stress

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

3.

Navigating the Complexities of Ph Negative ALL - Part I

4.

Current Scenario of Cancer- The Incidence of Cancer in Men

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot